Special Issue
Thymidylate synthase in biology and cancer treatment
Submission Deadline: 31 December 2004
Articles: 3
Special Issue Editor
Guest Editor
Bruce Dolnick
Member Professor, Pharmacology and Therapeutics, Elm and Carlton Streets, Buffalo, NY 14263
Expertise: 48 publications, 1 grant, Editor of Frontiers in Bioscience, Cancer Biology & Therapy, Clinical Colorectal Cancer
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see


Cell Biology, Molecular Biology
Share This Special Issue
Published Papers (3 papers)
Open Access
Thymidylate synthase: a critical target in cancer therapy?
Youcef M Rustum
Frontiers in Bioscience-Landmark Volume 9 Issue 4, pp.2467-2473
Managing Editor: Bruce Dolnick
DOI: 10.2741/1408 Published: 01 September 2004
Open Access
Pharmacogenomics of thymidylate synthase in cancer treatment
Peter V Danenberg
Frontiers in Bioscience-Landmark Volume 9 Issue 4, pp.2484-2494
Managing Editor: Bruce Dolnick
DOI: 10.2741/1410 Published: 01 September 2004
Open Access
Translational autoregulation of thymidylate synthase and dihydrofolate reductase
Ningwen Tai, John C Schmitz, Jun Liu, Xiukun Lin, Michelle Bailly, Tian-min Chen, Edward Chu
Frontiers in Bioscience-Landmark Volume 9 Issue 4, pp.2521-2526
Managing Editor: Bruce Dolnick
DOI: 10.2741/1413 Published: 01 September 2004